The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment

Testing for treatment related biomarkers in clinical care, like Ras mutation status in colorectal cancer (CRC), has increased drastically over recent years. Reliable testing of these markers is pivotal for optimal treatment of patients. Participation in external quality assessment (EQA) programs is...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Virchows Arch
Autores principales: Dijkstra, Jeroen R., Tops, Bastiaan B. J., Nagtegaal, Iris D., van Krieken, J. Han J. M., Ligtenberg, Marjolijn J. L.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Berlin Heidelberg 2015
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552773/
https://ncbi.nlm.nih.gov/pubmed/26047774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-015-1789-5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares